Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

  • ID: 3845342
  • Company Profile
  • 46 pages
  • Global Markets Direct
1 of 4
Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016

Summary

‘Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Jeil Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Jeil Pharmaceutical Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Jeil Pharmaceutical Co., Ltd.
- The report provides overview of Jeil Pharmaceutical Co., Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Jeil Pharmaceutical Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Jeil Pharmaceutical Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Jeil Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Jeil Pharmaceutical Co., Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Jeil Pharmaceutical Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Jeil Pharmaceutical Co., Ltd. Snapshot

Jeil Pharmaceutical Co., Ltd. Overview

Key Information

Key Facts

Jeil Pharmaceutical Co., Ltd. - Research and Development Overview

Key Therapeutic Areas

Jeil Pharmaceutical Co., Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Jeil Pharmaceutical Co., Ltd. - Pipeline Products Glance

Jeil Pharmaceutical Co., Ltd. - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Jeil Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Jeil Pharmaceutical Co., Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Jeil Pharmaceutical Co., Ltd. - Drug Profiles

(solifenacin succinate + tamsulosin hydrochloride)

Product Description

Mechanism of Action

R&D Progress

JLP-1401

Product Description

Mechanism of Action

R&D Progress

metformin hydrochloride + rosuvastatin calcium

Product Description

Mechanism of Action

R&D Progress

JJP-1305

Product Description

Mechanism of Action

R&D Progress

JPI-289

Product Description

Mechanism of Action

R&D Progress

JGK-263

Product Description

Mechanism of Action

R&D Progress

JLP-1601

Product Description

Mechanism of Action

R&D Progress

JLP-1604

Product Description

Mechanism of Action

R&D Progress

JP-1366

Product Description

Mechanism of Action

R&D Progress

JP-2266

Product Description

Mechanism of Action

R&D Progress

JPI-547

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Degenerative Arthritis

Product Description

Mechanism of Action

R&D Progress

Small Molecule for Hypertriglyceridaemia

Product Description

Mechanism of Action

R&D Progress

Stem Cell Therapy for Parkinson's Disease and Age-Related Macular Degeneration

Product Description

Mechanism of Action

R&D Progress

JLP-1602

Product Description

Mechanism of Action

R&D Progress

JLP-1603

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit FLT3 for Acute Myeloid Leukemia

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Neuropathic Pain

Product Description

Mechanism of Action

R&D Progress

Jeil Pharmaceutical Co., Ltd. - Pipeline Analysis

Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Target

Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration

Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type

Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action

Jeil Pharmaceutical Co., Ltd. - Recent Pipeline Updates

Jeil Pharmaceutical Co., Ltd. - Dormant Projects

Jeil Pharmaceutical Co., Ltd. - Company Statement

Jeil Pharmaceutical Co., Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Jeil Pharmaceutical Co., Ltd., Key Information

Jeil Pharmaceutical Co., Ltd., Key Facts

Jeil Pharmaceutical Co., Ltd. - Pipeline by Indication, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016

Jeil Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016

Jeil Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016

Jeil Pharmaceutical Co., Ltd. - Phase III, 2016

Jeil Pharmaceutical Co., Ltd. - Phase I, 2016

Jeil Pharmaceutical Co., Ltd. - Preclinical, 2016

Jeil Pharmaceutical Co., Ltd. - Discovery, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Target, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016

Jeil Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2016

Jeil Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2016

Jeil Pharmaceutical Co., Ltd., Other Locations 43List of Figures

Jeil Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2016

Jeil Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Target, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2016

Jeil Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll